Alzheimer's disease (AD) is an irreversible and progressive neurodegenerative disorder with no known cure or clear understanding of the mechanisms involved in the disease process. Amyloid plaques, neurofibrillary tangles and neuronal loss, though characteristic of AD, are late stage markers whose impact on the most devastating aspect of AD, namely memory loss and cognitive deficits, are still unclear. Recent studies demonstrate that structural and functional breakdown of synapses may be the underlying factor in AD-linked cognitive decline. One common element that presents with several features of AD is disrupted neuronal calcium signaling. Increased intracellular calcium levels are functionally linked to presenilin mutations, ApoE4 expression, amyloid plaques, tau tangles and synaptic dysfunction. In this review, we discuss the role of AD-linked calcium signaling alterations in neurons and how this may be linked to synaptic dysfunctions at both early and late stages of the disease.
Alzheimer's disease and the relevance of synaptic dysfunction
Alzheimer's disease (AD) is a devastating neurodegenerative disorder that gradually and insidiously destroys neurons, leading to cognitive, memory and behavior impairments. AD is definitively diagnosed through patient history of cognitive decline in conjunction with postmortem findings of amyloid beta (Aβ) plaques, neurofibrillary tau tangles and extensive neuronal loss in the hippocampus and neocortex. The most common form, termed sporadic AD, has a relatively late age of onset (>65 years of age), though its etiology remains a mystery. The inherited or familial form (FAD) exhibits a similar pattern of cognitive decline and histopathology, though the progression of symptoms is far more aggressive and the age of onset is markedly younger (30-40 years) . FAD is linked to mutations in the amyloid precursor protein (APP) and the presenilin (PS) 1 and 2 genes. While the mechanistic link between the development of AD and these gene mutations is unclear, their expression will invariably lead to AD [1, 2] .
The amyloid beta peptide, the primary component of plaques, is derived from altered processing of the amyloid precursor protein (APP). Sequential cleavage of APP by β-and γ-secretases results in production of Aβ peptides-the more common Aβ 40 and the pathogenic Aβ 42 . Presenilin forms the catalytic core of the γ-secretase enzyme complex and regulates the intramembranous cleavage of APP to Aβ. The majority of presenilin gene mutations studied in model systems have been shown to alter γ-secretase cleavage of APP, resulting in increased production of the toxic Aβ 42 [2] [3] [4] . These same presenilin mutations have also been linked to altered intracellular calcium signaling in a variety of model and cell systems, and will be the subject of further discussion later in this review.
Despite being an obligatory diagnostic feature of AD, Aβ and tau deposits are poorly correlated with the most devastating aspect of AD, namely the progressive memory loss and cognitive decline. In fact, both Aβ plaques and tau tangles are present in the hippocampus and neocortex of individuals without cognitive deficits or dementia, at levels similar to those found in individuals with dementia [5] [6] [7] [8] . More recent and convincing evidence implicates the breakdown of synaptic integrity and function as a better correlate, and likely causative agent, of cognitive decline in AD [9] [10] [11] [12] [13] [14] . These studies demonstrate not only neuronal loss but a reduction in dendritic arborization and dendritic spine density of pyramidal neurons in AD patients and animal models. Indeed, AD has increasingly been referred to as a "synaptic disease" because of the central role synaptic breakdown has in the devastating cognitive deficits of the disease [10, [15] [16] [17] . Although this review will focus on the proximal role calcium dysregulation has in promoting synaptic dysfunction in AD, it also is worth noting that other hallmark, but not exclusive, features of AD such as Aβ and hyperphosphorylated tau, also introduce synaptic pathology (as well as calcium dysregulation) [18] [19] [20] [21] . It is likely that the combined, feed-forward pathogenic cascades among these features will accelerate the demise of synapses in AD, though independently each can result in dysfunction.
There are several reasons why synaptic impairment is of principal significance to cognitive loss in AD. One of the observations in the brains of AD patients is a reduction in the number of dendritic spines and their connections with presynaptic terminals to anchor a functional synapse [11] [12] [13] [14] . Structurally, the dendrites of pyramidal neurons are covered with numerous spines, or protrusions, that serve as the postsynaptic sites for most excitatory synapses. Within these small compartments (~0.01 to 0.8 µm 3 ), an extensive array of cellular machinery is condensed which supports a unique signaling microcosm of receptors, scaffolding proteins, second messengers, kinases/phosphatases, gene transcription factors and immediate early genes, and, among other signaling factors, calcium [22, 23] . Here, calcium serves many functions, but the common denominator is its role in transducing and modifying neurochemical signals released from presynaptic terminals into electrical gradients (such as through voltage-gated calcium channels, and calcium-permeable postsynaptic receptors), and promoting downstream signaling cascades by activating calciumsensitive kinases, phosphatases, and the like [24, 25] . Because of the unique geometry of the spine head and neck, which confers a high resistance barrier to the adjacent dendritic process, the spine head signaling domain is protected to maintain proper synaptic transmission and plasticity properties, which in turn can support learning and memory functions within key brain regions [22, 23] . Therefore, localized calcium signals in dendritic spines and processes are central to proper neuronal activity and synaptic functioning, and sustained calcium dyshomeostasis can alter both the structural and functional aspects of the spine apparatus [26, 27] . This can occur in either the absence of amyloid or tau histopathology, or, become greatly accelerated in the presence of misfolded protein aggregates.
AD pathology, risk factors, and mechanisms of early calcium dyshomeostasis
Maintenance of intracellular calcium homeostasis is essential for the functioning and survival of neurons and is a fundamental component of synaptic transmission for both pre-and postsynaptic mechanisms [28, 29] . Given the crucial and widespread roles calcium signaling has in excitable cells, it is not surprising that alterations in calcium homeostasis are linked to several neurodegenerative conditions [30] [31] [32] [33] . Calcium concentrations in the cytosol are typically maintained at nanomolar levels but can locally be increased to micromolar levels within distinct microdomains such as outside channel pore regions and within enclosed domains such as spine heads [22, 34] . Cytosolic calcium entry is predominantly mediated by ligand-gated channels (such as NMDA receptors) or voltage-gated calcium channels (VGCC) located in the plasma membrane. Release of calcium from intracellular ER sources occurs via ER membrane channels-inositol trisphosphate receptor (IP 3 R) and ryanodine receptor (RyR). The IP 3 Rs are activated by the second messenger IP 3 while the RyRs are activated by cytosolic calcium. The activation of both of these channels is augmented by the phenomenon of calcium-induced calcium release (CICR) a regenerative process in which calcium enhances its own release from IP 3 R and RyR. This self-limiting dynamic enables the recruitment of ER calcium through a variety of calcium signaling pathways in neuronal physiology, serving in part as a coincidence detector across calcium sources. For instance, RyR-mediated CICR can be augmented by calcium entering through plasma membrane calcium channels as well as calcium released through the IP 3 R [35] [36] [37] . Mitochondrial calcium dynamics make a relatively smaller contribution, but are still an important component in regulating calcium homeostasis by quickly taking up excess calcium released from ER stores and slowly releasing it in the cytosol [38] .
Aberrant neuronal calcium signaling is increasingly implicated as a pathogenic factor in AD and is also observed with sporadic AD risk factors such as ApoE 4 expression and CALHM1 polymorphisms (Figure 1 ). The calcium dyshomeostasis resulting from AD-linked PS mutations, as well as presumed ApoE4 expression and CALHM polymorphisms, is present throughout the organism's lifetime [32, 39, 40] . This is in contrast to the emergence of amyloid plaques and tau tangles relatively late in one's lifetime-in both neurodegenerative disease states and as a part of normal aging. In familial and sporadic AD associated with genetic risk factors, the long-term exposure to genetic aberrations suggests that either cumulative lifelong challenges, or predisposing vulnerabilities to age-dependent or epigenetic insults, may contribute to the pathology resulting in AD. However, identifying the actual early pathogenic mechanisms has thus far been elusive save for increased ER calcium linked to PS mutations.
The effects of PS mutations on calcium dysregulation have been demonstrated in model cell systems, namely transgenic mice and human cells [41] [42] [43] [44] [45] [46] . Several mechanisms have been proposed for the effects of mutant PS on ER calcium signaling. One hypothesis suggests that PS, in its wild-type state, may function as an ER leak channel that maintains ER calcium homeostasis by releasing calcium and balancing SERCA (Sarco/Endoplasmic Reticulum Calcium ATPase) pump activity. Mutant PS may be impaired as a leak channel, and as a result, ER calcium stores become overfilled which can introduce homeostatic changes in RyR expression, protein misfolding, and other downstream consequences [47, 48] . Direct alterations of IP 3 R function have also been documented. Mutant PS1 has been shown to increase the open probability of the IP 3 R and to shift modal gating properties to bursts of repetitive openings at what would normally be sub-threshold IP 3 concentrations, resulting in net increased ER calcium release through these channels [49, 50] . Consistent with this, within the soma of mutant PS1-expressing neurons, baseline circulating levels of cytosolic IP 3 are sufficient to generate a modest IP 3 -evoked calcium response in the presence of elevated calcium (a necessary co-agonist at the IP 3 R), whereas in control neurons, this low-level [IP 3 ] is insufficient to activate the IP 3 R [16] .
There are also several lines of evidence demonstrating effects of mutant PS on RyR-mediated calcium release and CICR threshold. In mutant PS-expressing animal models, increased RyR-mediated calcium release is observed before the histopathological and cognitive symptoms emerge and persists throughout the organism's lifetime [46, 51] . Additionally, conditions which result in increased ER calcium levels can further enhance RyR responsivity to cytosolic calcium [52, 53] , thereby augmenting CICR and establishing a long-term feed-forward mechanism of calcium cycling. Direct modulation of RyR by PS may be one concrete mechanism by which ER calcium dyshomeostasis results. The PS1 N-terminal domain is thought to bind to and potentiate RyR calcium flux, and under normal conditions, the degree of calcium release is kept within physiological limits by a calcium-dependent negative feedback mechanism by which the RyR detects elevated calcium and subsequently suppresses further calcium release [54] . Mutant PS1 may impair this feedback function whereby RyR activity persists even at high calcium concentration. There is also evidence that PS1 mutations increase ryanodine receptor (RyR) expression levels in neurons [46, 51, 55] , with distinct isoform specific patterns. At early or presymptomatic stages, the RyR2 isoform is selectively upregulated and may underlie the exaggerated RyR-evoked calcium responses and sensitized CICR, while at later stages, coincident with Aβ 42 deposition, RyR3 levels upregulate in what is possibly a neuroprotective response [16, [56] [57] [58] . The RyR2 is densely expressed in several brain regions vulnerable in AD, especially the hippocampus, while the RyR3 expression patterns are typically more diffuse and relatively sparse [59, 60] . Notably, increased RyR2 expression is also observed in individuals with mild cognitive impairment (MCI), which is thought to be an early stage of dementia that ultimately will convert to AD [61] .
Resulting from this preexisting calcium dysregulation, a subsequent pathogenic cascade may develop between increased calcium levels and Aβ deposition in AD. Aβ oligomers may increase calcium influx by forming calcium pores in the plasma membrane and by regulating existing plasma membrane calcium channels [62] [63] [64] . Increased intracellular calcium, and more specifically, RyR-mediated calcium release, can in turn facilitate the formation of pathogenic Aβ peptides and plaque aggregation [65] [66] [67] , and equally increasing Aβ load can increase RyR3 expression [57] . An analogous facilitatory pathogenic relationship may exist between calcium signaling and tau pathology. Increased intracellular calcium potentiates neurofibrillary tangle formation by upregulating the activity of calcium-dependent tau kinases such as glycogen synthase kinase 3β, protein kinase C, cdk5 and others [68] . Conversely, hyperphosphorylated tau can further raise intracellular calcium concentrations by compromising the integrity of neuronal processes, altering signaling cascades, and upregulating cholinergic receptor activation coupled to calcium release [32] .
The known sporadic AD risk factors such as CALHM1 and ApoE4 allele expression also alter intracellular calcium levels. The CALHM1 gene encodes a transmembrane calcium permeable channel which is inserted in ER and plasma membranes. Recently, a polymorphism of CALHM1 was found that is associated with increased AD risk, increasing Aβ deposition by altering calcium permeability [40] . Apolipoprotein E (ApoE) is a lipid-associated protein involved in transport of lipids. There are three ApoE alleles, ApoE2, ApoE3 and ApoE4, each conferring distinct vulnerability to AD. Expressing ApoE2 is considered neuroprotective, while E4 expression is linked to increased risk of AD [69, 70] . ApoE4 increases intracellular calcium levels via a cell-surface LDL receptor-mediated process that recruits plasma membrane calcium channels as well as RyR-mediated ER stores [32] . Further, ApoE4 is found in close proximity to amyloid plaque, suggesting that it may play a role in Aβ formation and in a larger pathogenic process involving lipid metabolism, calcium, and protein folding [71] . 
Calcium channels, neurotransmission and synaptic plasticity
The dynamic interplay between calcium sources becomes particularly relevant when considering pre and postsynaptic mechanisms underlying neurotransmission and synaptic plasticity ( Figure 2 ) [28, [72] [73] [74] [75] . Presynaptically, ER calcium mediates neurotransmitter release via coupling of calcium binding sensors to neurotransmitter vesicles. CICR through the RyR may trigger spontaneous neurotransmitter release that is detected as miniature postsynaptic potentials [76, 77] . When presynaptic calcium levels are elevated in response to an action potential, the immediately releasable pool of neurotransmitter vesicles is released into the synaptic cleft. This is followed by a slow calcium-dependent phase during which the readily releasable pool is replenished from a reserve pool. CICR evoked by voltagedependent calcium entry can mobilize neurotransmitter vesicles from the reserve pool to the readily releasable pool and thus facilitate subsequent vesicle release [78, 79] . This calcium-dependent release has implications for short-term forms of plasticity such as paired pulse facilitation (PPF), a form of presynaptic plasticity. PPF involves residual calcium remaining in the presynaptic terminal following the initial stimulus, thus increasing the probability of neurotransmitter release when a second stimulus in rapid temporal succession additively increases calcium influx into the presynaptic terminal. ER stores may be a source for the residual calcium that contributes to PPF, and conditions that enhance CICR, such as PS mutations, may alter vesicle release probabilities. Post-tetanic potentiation (PTP) is another form of presynaptic plasticity that occurs following a high frequency stimulus. PTP reflects an enhancement of neurotransmitter release that leads to strengthening of the synapse for a brief period of time, typically on the order of seconds to minutes. PTP is also thought to involve residual calcium that results from voltage-gated calcium influx that accompanies a high frequency stimulus, and CICR recruited by voltage-gated calcium influx can increase residual calcium [75, 77, 79] . Postsynaptically, ER calcium initiates gene transcription [80] , modulates membrane excitability and channel function [81, 82] , and integrates with synaptically evoked responses to encode long term plasticity changes in neuron function [83, 84] . Dendritic spines are typically the initial loci of synaptic plasticity and contain several calcium channels such as NMDAR, AMPAR, VGCC, RyR and IP 3 R. Calcium in dendritic spines and dendrites regulates incoming electrochemical inputs for signal transmission through neurons, and depending on the combination of channels recruited, calcium influx can influence long-term changes in synaptic efficacy and plasticity. For example, NMDARmediated calcium entry into spines and dendrites is essential but not sufficient by itself for induction of LTP [79, 86] . ER calcium stores can amplify the initial NMDAR-mediated signal and determine the polarity as well as input specificity of long-term plasticity. For example, blocking ER calcium stores eliminates LTD and results in a switch to LTP under the same stimulus conditions. Similarly, with an LTP-inducing stimulus, blocking ER stores reduces LTP while stimulating intracellular calcium release facilitates LTP [56, 87, 88] .
Certain forms of calcium-dependent synaptic plasticity, including LTP and LTD, are thought to underlie the cellular/molecular mechanisms of learning and memory [89] [90] [91] . This has been demonstrated in studies where NMDA calcium channels or calcium-dependent kinases required for synaptic plasticity were manipulated, and learning and memory deficits resulted. Specifically, NMDA receptors are required not just for induction of LTP but also for establishing the duration and maintenance of LTP via activation of protein kinase Mζ (PKMζ), an isoform of protein kinase C. When blocking NMDA receptors or PKMζ , LTP is abolished and spatial learning, particularly the generation and maintenance of new place fields, is disrupted [92] [93] [94] [95] [96] . Similarly, rodents lacking the essential NR1 subunit of the NMDA receptor demonstrate disrupted place cell function and are unable to locate a hidden platform in the Morris water maze, suggesting that calcium-permeable channels are crucial in spatial learning and memory [97] .
Not only are changes in calcium levels important for transmission and plasticity induction, but the spatial and temporal patterns are critical encoding parameters as well. At synapses that support bidirectional plasticity, the induction of either LTP or LTD depends on the magnitude and temporal aspects of intracellular calcium dynamics-large and transient calcium rises are associated with LTP whereas modest and sustained calcium rises are associated with LTD [86, 88, 98] . Calcium/calmodulin-dependent protein kinase II (CAMKII) required for induction of LTP has low affinity for calcium and is activated when there are large but transient increases in postsynaptic calcium [99, 100] . CAMKII together with protein kinase A (PKA) activate several downstream signaling cascades that drive AMPAR into the synapse [101] [102] [103] as well as CREB-dependent transcription of proteins that sustain synaptic plasticity [104] . On the other hand, calcineurin or protein phosphatase 2B (PP2B) associated with LTD has a much higher affinity for calcium and is activated by modest and sustained increases in postsynaptic calcium [105, 106] . Activation of calcineurin leads to dephosphorylation and internalization of AMPA receptors from the synapse and therefore results in a reduction in synaptic strength [107] [108] .
The precise role of intracellular calcium stores in these processes is complex and may depend on the mechanism of calcium release from the ER (Figure 2) . In neurons, the ER forms a continuous network that extends throughout the dendritic tree and into dendritic spines [109, 110] . In CA1 pyramidal neurons, the ER in the soma and dendritic shafts express both IP 3 R and RyR, while ER networks in distal processes and dendritic spine heads express a greater proportion of RyR [80, 112] . This suggests that calcium signaling involving these individual receptors may support different roles in synaptic activity-the IP 3 Rs may be involved in gene transcription and protein synthesis in the soma, while RyRs may be better positioned to modulate incoming synaptic activity directly in dendritic spine heads or subthreshold signals that are confined to the isolated geometry of the spine heads, whereas IP 3 R activation may enter extrasynaptic signaling pathways or require much higher threshold inputs. For example, in dendritic spines of hippocampal CA1 neurons, the NMDAR-mediated calcium signal is largely amplified by RyR-mediated CICR [78, 113] . Blocking RyR with dantrolene obstructs the induction of LTP [56, 114, 115] as well as LTD (Chakroborty, unpublished findings), indicating that RyR-mediated ER calcium is required for sustained plasticity and by association, memory and related cognitive functions. Additional evidence for the fundamental role of RyR in synaptic plasticity emerges from studies using RyR knockout mice. For example, RyR3 knockout mice show enhanced LTP which is independent of NMDAR-mediated mechanisms, but also exhibit impaired LTD [116] . The RyR3 is expressed in dendritic processes of hippocampal neurons [60] , suggesting that RyR3 isoform may function to suppress LTP and facilitate LTD. This may in turn serve to maintain the balance of excitation and inhibition that determines the overall stability of the synapse.
There also appears to be functional overlap between RyR and IP 3 R-mediated calcium signaling and plasticity. Type 1 IP 3 R knockout mice also demonstrate enhanced LTP, while LTD is not affected [117] , suggesting that IP 3 R-sensitive ER calcium stores in general have an inhibitory role in LTP induction. Furthermore, IP 3 R-mediated calcium stores outside dendritic spines may also suppress LTP in neighboring synapses, thus maintaining the input specificity that is characteristic of LTP. The differences in the effects of RyR and IP 3 R-mediated calcium signaling on synaptic plasticity, especially LTD, may reflect their anatomical and kinetic Figure 2 Possible ER calcium-dependent plasticity mechanisms in axon terminals and dendritic spines. A, at the presynaptic axon terminal-① CICR can occur spontaneously to trigger synaptic vesicle release. During high frequency activity, CICR can be evoked by voltage-gated calcium influx to increase the residual calcium levels and release probability. ② ER calcium release is implicated in endocytosis of fused vesicles to the reserve pool and mobilization of vesicles to the readily releasable pool. B, At the postsynaptic terminal-① NMDAR-mediated calcium signal is amplified by RyR in dendritic spines and is probably necessary for homosynaptic plasticity. ② mGluR-mediated activation of the phospholipase C (PLC) pathway generates IP 3 . Subsequent activation of IP 3 Rs supports regenerative calcium waves, which may be involved in heterosynaptic plasticity and gene expression. differences in coupling to different calcium stores.
Effects of altered ER calcium on neurophysiology: Implications for AD pathogenesis
As implied in the preceding discussion, maintaining calcium homeostasis is crucial for synaptic activity and plasticity. Therefore, AD-linked mechanisms that interfere with calcium signaling are important to investigate from both a disease-manifesting and therapeutic standpoint. For example, PS mutations result in RyR-mediated ER calcium signaling disruptions which occur prior to AD histopathology and persist through old age [32, 46] . Previous studies in 3×Tg-AD mice expressing mutant PS, APP and tau demonstrate synaptic dysfunction coincident with the detection of intracellular Aβ deposits [44] . Yet prior to this stage, synaptic transmission appears normal. This is consistent with several studies in AD models suggesting that synaptic transmission is unaffected until amyloid deposits form [25, 118] . Recent studies suggest that it is the soluble Aβ oligomers, and not insoluble amyloid plaques, that can cause synaptic dysfunction by disrupting intracellular calcium homeostasis via the formation of calcium-permeable channels [119] [120] [121] [122] . The increased cytosolic calcium levels due to Aβ-calcium channels not only increase metabolic stress but also contribute to a decrease in spine density and dystrophy and aberrant sprouting of dendrites, resulting in synaptic dysfunction [123] [124] [125] . These studies have contributed to the view that Aβ is the underlying mechanism driving synaptic dysfunction. Yet, more detailed examination into the role of ER calcium stores at early stages, prior to Aβ formation reveals pronounced deficits in baseline synaptic function that exist 'below the radar' of detection. A recent study in young 3×Tg-AD mice shows that dysregulated RyR-mediated ER calcium release alters hippocampal synaptic transmission and plasticity long before onset of AD histopathology (Figure 3 ) [56] . Under control conditions, basal synaptic transmission, PPF and LTP appear similar between the nontransgenic (NonTg) and AD mice. However, when the ER calcium contribution is manipulated, marked differences in the mechanisms underlying synaptic transmission and plasticity now emerge. Under conditions when the RyRs are blocked and the enhanced CICR effect is suppressed, the AD neurons now demonstrate enhanced basal synaptic transmission and altered short and long term plasticity, with no effects seen in the NonTg mice. For example, the I/O function and PPF were increased in AD neurons but remained unchanged in NonTg mice. This suggests that RyRmediated calcium has a prominent inhibitory effect in basal synaptic transmission and presynaptic neurotransmitter release in the AD mice but has little role in NonTg mice under these conditions. There are additional aberrant contributions of ER calcium to synaptic plasticity as well in the AD mice. In NonTg mice, RyR blockade had no effect on baseline responses, though LTP expression was reduced, a finding consistent with existing literature [126] . Yet, in AD mice, blocking RyR with dantrolene decreased baseline responses and produced a shift from LTP to modest LTD. Further di- vergent effects of ER calcium contribution to plasticity are seen with LTD-generating paradigms. RyR blockade enhances LTD in AD mice, while completely abolishing LTD in NonTg mice (Chakroborty, unpublished data) . Therefore, without RyR blockade, there appears to be no differences in synaptic transmission or plasticity between young AD and NonTg mice, suggesting that compensatory mechanisms may mask these alterations early on in the disease process but may break down as the disease progresses. Consistent with these findings regarding the role of RyR-mediated calcium signaling in presynaptic transmission is another recent study utilizing conditional knockouts (cDKO) of PS1 and PS2 in either the pre or postsynaptic neurons at the Schaffer collateral synapse. Presenilins may modulate the role of presynaptic ER calcium in neurotransmitter release and in induction of LTP, and loss of PS function may result in dysfunctional presynaptic neurotransmission via a RyR-dependent mechanism. Conditional inactivation of PS in CA3 neurons from PS cDKO mice reduces neurotransmitter release, synaptic facilitation and markedly impairs LTP, while conditional inactivation of PS in postsynaptic CA1 neurons does not affect these functions [126] . RyR blockade also decreases synaptic facilitation in CA3 neurons of PS cDKO mice, suggesting that presynaptic deficits are mediated by RyR-sensitive calcium stores. These findings are further supported by earlier studies using PS1 knockout (KO) neurons as well as PS1 mutant mice. In these studies, PS1 mutant mice exhibit increased magnitude of LTP, while PS1 KO neurons are impaired in several calcium-dependent aspects of synaptic transmission [127, 128] . These neurons have altered synaptic connections reflected by changes in spine morphology and spine density, and they show a redistribution of proteins critical for synaptic function such as PSD-95 and AMPA receptors. There is also upregulation of the PKA-cAMP signaling pathway that regulates CREB-dependent transcription, suggesting that these changes may ultimately impair synaptic transmission and plasticity, and therefore memory processes, in a manner that reflects upstream calcium signaling alterations.
Summary
Intracellular calcium signaling is crucial to neuronal function, synaptic transmission, and plasticity mechanisms underlying learning and memory. Owing to its ubiquitous role, sustained disruptions in calcium signaling have significant ramifications for neuronal and cognitive health over the lifetime of the organism. Current research suggests that the early disruptions in calcium homeostasis observed in AD incur pathogenic insults and are not inherent to normal aging [32, 46, 129] . Even though the direct mechanistic link between calcium dysregulation and AD pathology is still under investigation, one might surmise that calcium-mediated pathogenesis reflects a lifetime of gradually accumulating stressors and has multiple diffuse targets affecting many cellular systems. Eventually, these stressors become part of a feedforward pathological cascade that later facilitate Aβ and tau deposition, ER and mitochondrial stress, loss of synapses, and ultimately, loss of memory ( Figure 1 ) [32, [129] [130] [131] . Therefore, considering calcium dyshomeostasis as an integral component of AD-linked synaptic pathology may yield new insights into the cellular mechanisms of cognitive deficits and offer novel therapeutic interventions.
